Flavonol quartiles^{*} (mg/d) | Adenoma recurrence (T4) | ||||||
---|---|---|---|---|---|---|---|

No | Advanced | High-risk | Any | ||||

n (%) | n (%) | OR (95% CI)^{†} | n (%) | OR (95% CI)^{†} | n (%) | OR (95% CI)^{†} | |

<21.2 | 128 (58.7) | 25 (11.5) | 1.00^{‡} | 40 (18.3) | 1.00^{‡} | 90 (41.3) | 1.00^{‡} |

21.2-29.7 | 134 (61.5) | 11 (5.0) | 0.35 (0.16-0.76) | 22 (10.1) | 0.49 (0.27-0.90) | 84 (38.5) | 0.89 (0.60-1.33) |

29.8-40.0 | 124 (56.9) | 8 (3.7) | 0.32 (0.13-0.77) | 19 (8.7) | 0.54 (0.28-1.01) | 94 (43.1) | 1.16 (0.78-1.72) |

>40.0 | 138 (63.3) | 5 (2.3) | 0.17 (0.06-0.50) | 19 (8.7) | 0.51 (0.26-0.98) | 80 (36.7) | 0.96 (0.63-1.46) |

P-trend^{§} | 0.0002 | 0.02 | 0.87 |

↵*Flavonol intake in quartiles (Q1-Q4) by the mean consumption during the first 3 trial years.

↵

^{†}Multivariate OR and 95% CI models were adjusted for age tertiles (<58, 58-66, >66 y), sex, average BMI (<25, 25.0-29.9, ≥30 kg/m^{2}), and average energy intake (continuous) during the first 3 trial years.↵

^{‡}Reference category.↵

^{§}The ln-transformed median intakes (in mg/d) of each quartile were used as a continuous score variable to determine the*P*value for trend.